Optimizing Phosphopeptide Structures That Target 14-3-3ε in Cutaneous Squamous Cell Carcinoma

Optimizing Phosphopeptide Structures That Target 14-3-3ε in Cutaneous Squamous Cell Carcinoma

Bibliographic Details
Main Authors:	Seraphine Kamayirese, Sibaprasad Maity, Lynne M. Dieckman, Laura A. Hansen, Sándor Lovas
Format:	Article
Language:	English
Published:	American Chemical Society 2024-01-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.3c07740

Similar Items

Molecular targeted therapies for cutaneous squamous cell carcinoma
by: Harpreet Singh, et al.
Published: (2024-02-01)

Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated Keratin 14 degradation
by: Kaili Zhou, et al.
Published: (2024-04-01)

C1s targeting antibodies inhibit the growth of cutaneous squamous carcinoma cells
by: Liisa Nissinen, et al.
Published: (2024-06-01)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Vivek V. Gurudutt, et al.
Published: (2011-01-01)

Photodynamic therapy of cutaneous squamous cell carcinoma
by: E. V. Filonenko, et al.
Published: (2024-12-01)

Antibody-platinum (IV) prodrugs conjugates for targeted treatment of cutaneous squamous cell carcinoma
by: Xiangye Yin, et al.
Published: (2024-03-01)

Targeting receptor tyrosine kinase signaling: Avenues in the management of cutaneous squamous cell carcinoma
by: Mohan Shankar Gopinatha Pillai, et al.
Published: (2023-06-01)

14–3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer
by: Yue Zhang, et al.
Published: (2024-01-01)

The Role of the Immune System in Cutaneous Squamous Cell Carcinoma.
by: Bottomley, M, et al.
Published: (2019)

Cemiplimab Immunotherapy in the Treatment of Cutaneous Squamous Cell Carcinoma
by: Z. Kozéki, et al.
Published: (2024-01-01)

Statins Inhibit Cutaneous Squamous Cell Carcinoma Cells
by: Asher Hackett, et al.
Published: (2024-08-01)

Involvement of Kindlin-1 in cutaneous squamous cell carcinoma
by: Giovana Carrasco, et al.
Published: (2024-07-01)

Extra-Anogenital Giant Cutaneous Squamous Cell Carcinomas
by: Mateusz K. Mateuszczyk, et al.
Published: (2024-03-01)

Surgical outcomes for cutaneous squamous cell carcinoma of the auricle
by: Constantin Manole, et al.
Published: (2023-12-01)

Deep mycosis mimicking cutaneous squamous cell carcinoma
by: Fortunato Cassalia, et al.
Published: (2023-08-01)

German S3 guideline “actinic keratosis and cutaneous squamous cell carcinoma” – Long version of the update 2023
by: Ulrike Leiter, et al.
Published: (2023-01-01)

3D-printed Model and guide plate for accurate resection of advanced cutaneous squamous cell carcinomas
by: Weiqian Jiang, et al.
Published: (2023-01-01)

Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios
by: Komal Akhtar MD, et al.
Published: (2022-08-01)

Phosphopeptide fragmentation and analysis by mass spectrometry.
by: Boersema, P, et al.
Published: (2009)

Molecular mechanism of phosphopeptide neoantigen immunogenicity
by: Yury Patskovsky, et al.
Published: (2023-06-01)

Casein Phosphopeptides in oral and dental health
by: M Ghafournia
Published: (2009-01-01)

Tissue eosinophilia in oral and cutaneous squamous cell carcinoma and normal oral and cutaneous tissues
by: Reyhane Kargar, et al.
Published: (2017-07-01)

STAT3 and Its Targeting Inhibitors in Oral Squamous Cell Carcinoma
by: Mingjing Jiang, et al.
Published: (2022-10-01)

Distinct transcriptomic landscapes of cutaneous basal cell carcinomas and squamous cell carcinomas
by: Jun Wan, et al.
Published: (2021-03-01)

The role of p53 in the immunobiology of cutaneous squamous cell carcinoma.
by: Black, A, et al.
Published: (2003)

Radiotherapy for cutaneous squamous cell carcinoma: current standards and outlooks
by: A. R. Gevorkov, et al.
Published: (2022-12-01)

Outcomes of Recurrent Head and Neck Cutaneous Squamous Cell Carcinoma
by: Nichole R. Dean, et al.
Published: (2011-01-01)

Cutaneous Squamous Cell Carcinoma with Invasion through Ear Cartilage
by: Julie Boisen, et al.
Published: (2016-01-01)

Paraneoplastic bullous pemphigoid secondary to cutaneous squamous cell carcinoma
by: Karolina Zarańska, et al.
Published: (2025-01-01)

Histopathological Variants of Cutaneous Squamous Cell Carcinoma: A Review
by: Valerie R. Yanofsky, et al.
Published: (2011-01-01)

Suspected Pulmonary Metastasis of Actinic Cutaneous Squamous Cell Carcinoma
by: Monet E. Meter, et al.
Published: (2017-01-01)

Cutaneous squamous cell carcinoma in patients with solid organ malignancy
by: Chandler Johnson, BS, et al.
Published: (2024-06-01)

An overview of cutaneous squamous cell carcinoma imaging diagnosis methods
by: Sorina Danescu, et al.
Published: (2024-04-01)

Expression levels of INHBA are increased in cutaneous squamous cell carcinoma
by: Xue CAO, et al.
Published: (2023-04-01)

Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma
by: Glenn Geidel, et al.
Published: (2022-03-01)

Resimmune, an anti-CD3ε recombinant immunotoxin, induces durable remissions in patients with cutaneous T-cell lymphoma
by: Arthur E. Frankel, et al.
Published: (2015-06-01)

Clinical Risk Factors for Cutaneous Squamous Cell Carcinoma in Patients with Actinic Keratosis or Cutaneous Squamous Cell Carcinoma in Situ: A Retrospective Double-cohort Study
by: Jaakko S. Knuutila, et al.
Published: (2024-11-01)

Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Doriana Iancu, et al.
Published: (2025-01-01)

Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck
by: T. J. Phillips, et al.
Published: (2019-10-01)

Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
by: T. Van Meerhaeghe, et al.
Published: (2022-10-01)